Shahinian Lacrimal Cannula

Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea

For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters.

...technology developed over Guidants 20-year history...new foundation for successful treatment outcomes. ...with a lower profile shaft,more flexible markers, ...ross tight and tortuous anatomy with even greater ...

...nt AFP IRMA,is an immunoradiometric assay design...etoprotein (AFP) in serum. It is,intended strict..., (a) serial measurements to aid in the,manageme...ancer and,other conditions associated with abnor...

(Date:12/3/2008)... Deployed in partnership with The Sales Manag...Survey asks insightful questions to reveal a sales...ereby uncovering opportunities for improvement. ,...ber 3, 2008 -- Axiom Consulting Partners LLC anno...s Return On Sales Investment Survey., , , , ,The ...

(Date:12/3/2008)... Professional Development Resources, a nation... and social work continuing education (CE) since 1...t allows visitors to browse, purchase, and complet...m. Licensed mental health professionals in most st...ciencies by completing a specified number of hours...

(Date:12/3/2008)... ORSupply.com expands its selection of high q...ude full diagnostic product lines from Littmann an... (Vocus) December 3, 2008 -- Littmann and Heine st....com, the Internet’s largest marketplace for...Littman and Heine stethoscopes to its online store...

(Date:12/3/2008)... AGA Medical Corporation announced,...te Europeenne) approval for,its AMPLATZER(R) Card...nimally,invasive solution for closing cardiac str...ntended use will be for the non-surgical occlusion...is an important addition to the interventional too...

...Chromosome 16 boosts the risk of developing Type 1...causes of this disease . Three variants of a gene... genetic profiling of 563 patients with Type 1 dia...red to 1,146 healthy people, says the study, publi...

...the menu in southern China, after traders there ca...uring Hunan province, according to various state p...e Information Times from Guangzhou, trucks full of...g late at night and sold to a wild animal market i...

...nternational (HMI) will build a 60-acre health and...alth and medical needs of the people of the capita...s part of a large-scale residential development pl... City in the capital, and includes a 500-bed teach...

...f athletic hernia using tension-free mesh and a st...in returning athletes to competition, according t...eeting of the American Orthopaedic Society for Spo...nter. Dr. Brunt and colleagues studied the result...

(Date:12/1/2008)...announced that an oral,presentation of prelimina...,trial of TG101348 in myeloproliferative disease p...ociety of Hematology (ASH) Meeting. , , Det...tle: A Phase I Study of TG101348, an ...Selective Inhibitor, in Patients with, ...

(Date:12/1/2008)...y switch that, if turned off, causes lymphatic end...e their identity and become more like blood endoth...ewswire-USNewswire/ -- Scientists at St. Jude Chi...ertain differentiated cell type is so ready to cha...ression of a gene called Prox1 to dissuade it. ...

(Date:12/1/2008)...ber 9 at 11:00 am ET to Discuss Phase 2 Study Resu...if., Dec. 1 Sunesis Ph...ceutical company focused on the development and co...y announced new data from its studies of voreloxin... during the 50th American Society of Hematology (A...

(Date:11/30/2008)...rmalities in auditory and language processing may ...rder by using magnetoencephalography (MEG), accord...ng of the Radiological Society of North America (R...y magnetic fields associated with electrical brain...r of research in the Department of Radiology at Ch...

...SINESS WIRE)--Jul 3, 2007 - Nymox,Pharmaceutical C...ther clinical results from the Company,s studies o...ill be presented at the New,England Section of the... in September. The paper is authored by leading cl...rials of NX-107., The Company previously completed...

...ESS WIRE)--Jul 5, 2007 - Australian,biotechnology ...tion of apricitabine,s controlled, double blinded ...f its Phase IIb trial.,Patients have now progresse...24 to 48) and will continue to receive 800mg,apric...nt regime.,The Company expects to release results ...